{"name":"SIFI SpA","slug":"sifi-spa","ticker":"","exchange":"","domain":"sifispa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"NETILDEX™ eye drops solution","genericName":"NETILDEX™ eye drops solution","slug":"netildex-eye-drops-solution","indication":"Bacterial conjunctivitis with inflammation","status":"phase_3"},{"name":"NETILDEX™ ophthalmic gel","genericName":"NETILDEX™ ophthalmic gel","slug":"netildex-ophthalmic-gel","indication":"Bacterial ocular infections with associated inflammation","status":"phase_3"},{"name":"PHMB 0.02%","genericName":"PHMB 0.02%","slug":"phmb-0-02","indication":"Ophthalmic antimicrobial use (contact lens disinfection, eye care)","status":"phase_3"},{"name":"Propamidine 0.1%","genericName":"Propamidine 0.1%","slug":"propamidine-0-1","indication":"Acanthamoeba keratitis","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"PHMB 0.08%","genericName":"PHMB 0.08%","slug":"phmb-0-08","indication":"Treatment of blepharitis","status":"phase_3"},{"name":"Pro-ocular gel","genericName":"Pro-ocular gel","slug":"pro-ocular-gel","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"NETILDEX™ eye drops solution","genericName":"NETILDEX™ eye drops solution","slug":"netildex-eye-drops-solution","phase":"phase_3","mechanism":"NETILDEX combines netilmicin (an aminoglycoside antibiotic) with dexamethasone (a corticosteroid) to provide antimicrobial and anti-inflammatory effects in the eye.","indications":["Bacterial conjunctivitis with inflammation","Bacterial keratitis","Post-operative ocular inflammation and infection prophylaxis"],"catalyst":""},{"name":"NETILDEX™ ophthalmic gel","genericName":"NETILDEX™ ophthalmic gel","slug":"netildex-ophthalmic-gel","phase":"phase_3","mechanism":"NETILDEX is a combination ophthalmic gel containing netilmicin (an aminoglycoside antibiotic) and dexamethasone (a corticosteroid) that reduces bacterial infection and inflammation in the eye.","indications":["Bacterial ocular infections with associated inflammation","Post-operative ocular inflammation and infection prophylaxis"],"catalyst":""},{"name":"PHMB 0.02%","genericName":"PHMB 0.02%","slug":"phmb-0-02","phase":"phase_3","mechanism":"PHMB (polyhexamethylene biguanide) is a broad-spectrum antimicrobial agent that disrupts bacterial and fungal cell membranes.","indications":["Ophthalmic antimicrobial use (contact lens disinfection, eye care)","Wound irrigation and antimicrobial treatment"],"catalyst":""},{"name":"PHMB 0.08%","genericName":"PHMB 0.08%","slug":"phmb-0-08","phase":"phase_3","mechanism":"PHMB is an antimicrobial agent that works by disrupting the cell membrane of microorganisms.","indications":["Treatment of blepharitis"],"catalyst":""},{"name":"Pro-ocular gel","genericName":"Pro-ocular gel","slug":"pro-ocular-gel","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Propamidine 0.1%","genericName":"Propamidine 0.1%","slug":"propamidine-0-1","phase":"phase_3","mechanism":"Propamidine is an antiprotozoal agent that works by inhibiting the growth of protozoa.","indications":["Acanthamoeba keratitis","Naegleria fowleri infection"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPVk81cU9UVmFnT0NyU3hXVFV5QmJFMlJkRFNaWTBVVGhybHItU2VNeEkxX1J1VzlBTzhWcXh0dmNPNE51YWFLakktQ2VLb2pweml3SG96dUNqUWFRNjZyX1MwVFZkUFlGNHJmYjYtVUNDdFBVZEhfUkhfckczYzMwQk1pWmkxNFMzbFJpQVpMajdEZ3B6V1NFRjVIdkstenhXd0RZYXU0bEdpSTNFZ1hiRlRzcTlHUHRKbU8wV09LbkdyMEtTZE0w?oc=5","date":"2023-01-10","type":"deal","source":"PR Newswire","summary":"SIFI ANNOUNCES LICENSE AGREEMENT WITH AVANZANITE BIOSCIENCE FOR AKANTIOR® - PR Newswire","headline":"SIFI ANNOUNCES LICENSE AGREEMENT WITH AVANZANITE BIOSCIENCE FOR AKANTIOR®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOTW1UQU5sbGFWZkZtckM5dS0yVWpjVFB6RmlKU1JZUDhzT2dwcUREVmhOM09zMjE5eGJpMGZRRlRfQ3JEamhyS3ZQTkY2d3RsbFhIdHVlOUU3c09Dc09nNmp3MHRiVFh1b2RnWHNLRDNLcW9jOE82Z1Vfd2d3aHl2ZjNpdEtfNklPM29yeXlmdWxOV0V6cE1HeDhxcnFUcVIxdm5nNnc5Z2pqZ3FyTFlRd1JySktGVEN1ZmktRkpxZlByLVF6WUcxS3VZQ1RvNHd1MjY0UVN4UHRuM2V0RU5IRjl0ZV9wSlZ0ZEVnMS1IVi1URk1qbkVlQjlKZXNUYlFQWHFPVmE5MFdPT1FCSGRIWFJERVA3VXdfYWRmNDI1aGh2NlNieFZYREVqc0JDU2h6Mnc?oc=5","date":"2021-05-17","type":"deal","source":"PR Newswire","summary":"SIFI and Bausch Health Russia Announce Strategic Commercial Partnership that Will Ensure Greater Access to Important Eye Care Medicines in Russia - PR Newswire","headline":"SIFI and Bausch Health Russia Announce Strategic Commercial Partnership that Will Ensure Greater Access to Important Eye","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_3":5,"phase_2":1},"enrichmentLevel":2,"visitCount":9,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}